ELAN vs. TEVA, ITCI, GMAB, RDY, ASND, MRNA, VTRS, QGEN, ROIV, and LNTH
Should you be buying Elanco Animal Health stock or one of its competitors? The main competitors of Elanco Animal Health include Teva Pharmaceutical Industries (TEVA), Intra-Cellular Therapies (ITCI), Genmab A/S (GMAB), Dr. Reddy's Laboratories (RDY), Ascendis Pharma A/S (ASND), Moderna (MRNA), Viatris (VTRS), Qiagen (QGEN), Roivant Sciences (ROIV), and Lantheus (LNTH). These companies are all part of the "pharmaceutical products" industry.
Elanco Animal Health vs.
Elanco Animal Health (NYSE:ELAN) and Teva Pharmaceutical Industries (NYSE:TEVA) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, media sentiment, risk, earnings, community ranking and profitability.
Elanco Animal Health has a beta of 1.44, meaning that its share price is 44% more volatile than the S&P 500. Comparatively, Teva Pharmaceutical Industries has a beta of 0.72, meaning that its share price is 28% less volatile than the S&P 500.
Elanco Animal Health has a net margin of 4.60% compared to Teva Pharmaceutical Industries' net margin of -9.91%. Teva Pharmaceutical Industries' return on equity of 42.46% beat Elanco Animal Health's return on equity.
In the previous week, Elanco Animal Health had 2 more articles in the media than Teva Pharmaceutical Industries. MarketBeat recorded 18 mentions for Elanco Animal Health and 16 mentions for Teva Pharmaceutical Industries. Teva Pharmaceutical Industries' average media sentiment score of 1.25 beat Elanco Animal Health's score of 0.42 indicating that Teva Pharmaceutical Industries is being referred to more favorably in the news media.
97.5% of Elanco Animal Health shares are held by institutional investors. Comparatively, 54.0% of Teva Pharmaceutical Industries shares are held by institutional investors. 0.9% of Elanco Animal Health shares are held by company insiders. Comparatively, 0.6% of Teva Pharmaceutical Industries shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Teva Pharmaceutical Industries received 1193 more outperform votes than Elanco Animal Health when rated by MarketBeat users. Likewise, 67.84% of users gave Teva Pharmaceutical Industries an outperform vote while only 54.62% of users gave Elanco Animal Health an outperform vote.
Elanco Animal Health has higher earnings, but lower revenue than Teva Pharmaceutical Industries. Teva Pharmaceutical Industries is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks.
Elanco Animal Health currently has a consensus price target of $14.67, indicating a potential upside of 55.20%. Teva Pharmaceutical Industries has a consensus price target of $23.43, indicating a potential upside of 57.45%. Given Teva Pharmaceutical Industries' stronger consensus rating and higher probable upside, analysts plainly believe Teva Pharmaceutical Industries is more favorable than Elanco Animal Health.
Summary
Elanco Animal Health and Teva Pharmaceutical Industries tied by winning 9 of the 18 factors compared between the two stocks.
Get Elanco Animal Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for ELAN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Elanco Animal Health Competitors List
Related Companies and Tools
This page (NYSE:ELAN) was last updated on 4/27/2025 by MarketBeat.com Staff
Buy ELAN Stock Free ELAN Stock Alerts